Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kali Prasad Pattnaik"'
Autor:
Priti Das, Kaumudee Pattnaik, Kali Prasad Pattnaik, Somi Patra, Poornima Khadanga, Atanu Mohanty
Publikováno v:
International Journal of Contemporary Medical Research [IJCMR]. 7
Publikováno v:
Journal of Evidence Based Medicine and Healthcare, Vol 4, Iss 41, Pp 2477-2480 (2017)
BACKGROUND S-Adenosyl-L-Methionine (SAM) protects liver cells in viral hepatitis and paracetamol-induced hepatic damage, etc. But, there are scanty data regarding hepatoprotective effect of SAM in isoniazid-induced liver damage. With this background,
Autor:
Kali Prasad Pattnaik
Publikováno v:
Journal of Medical Science And clinical Research. :19680-19688
Autor:
Swayam Sourav Sahoo, Sibasis Patro, Ratikanta Tripathy, Kali Prasad Pattnaik, Srikanta Mohanty, Suhasini Dehury, Prasanjeet Mohanty
Publikováno v:
Indian Journal of Pharmacology
OBJECTIVES: To identify the association of cutaneous adverse drug reactions (CADRs) with use of fixed-dose combinations (FDCs) and to compare the occurrence of preventable CADRs between self-medication and prescribed medication of FDCs. PATIENTS AND
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 9:1520
Background: In Multi drug resistant falciparum malaria anti-malarial combinations are frequently used i.e. Quinine and IV Artesunate. Quinine is associated with electrocardiographic disturbances. Artesunate in high dose produce QTC prolongation in an
Publikováno v:
Journal of Current Pharma Research. 1:254-259
Publikováno v:
International Journal of Research in Medical Sciences. 5:2931
Background: Interventions that target blood pressure control and proteinuria, specifically interruption of the Renin-angiotensin-aldosterone system (RAAS), have been utilized in attenuating cardiovascular complications. Angiotensin receptor blockers
Autor:
Swayam Sourav Sahoo, Jigyansa Mohapatra, Susandhya Devadarshini, Rajashree Samal, Kali Prasad Pattnaik
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 6:1254
Background: Fluoroquinolones are generally well tolerated; most adverse effects are mild and common are GI upset. But recent literatures suggest increase reports of Cutaneous Drug reactions (CDRs) including SJS with Fluoroquinolones. However there is